1.
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
by Kakkar, Ajay K, Prof
The Lancet (British edition), 2008, Vol.372 (9632), p.31-39
2.
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
by Goette, Andreas, Prof
The Lancet (British edition), 2016, Vol.388 (10055), p.1995-2003
3.
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
by Lassen, Michael Rud, Dr
The Lancet (British edition), 2010, Vol.375 (9717), p.807-815
4.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
by Eriksson, Bengt I, Dr
The Lancet (British edition), 2007, Vol.370 (9591), p.949-956
5.
Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery...
by Svensson, Leif
The American heart journal, 2006, Vol.151 (4), p.798.e1-798.e7
6.
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
by Turpie, Alexander GG, MD
The Lancet (British edition), 2009, Vol.373 (9676), p.1673-1680
7.
8.
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Tria...
by Stone, Gregg W, Prof
The Lancet (British edition), 2007, Vol.369 (9565), p.907-919
9.
Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?
by Huber, Kurt, MD
The American heart journal, 2014, Vol.168 (5), p.611-621
10.
Utility of anti-Factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis
by Pannucci, Christopher J., MD MS
The American journal of surgery, 2016, Vol.213 (6), p.1143-1152
11.
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison
by Lassen, Michael Rud
The Lancet (British edition), 2002, Vol.359 (9319), p.1715-1720
12.
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial
by Turpie, Alexander GG
The Lancet (British edition), 2002, Vol.359 (9319), p.1721-1726
13.
The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial
by Gibson, C. Michael
The American heart journal, 2016, Vol.185, p.93-100
14.
Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
by Kleber, Franz-Xaver
The American heart journal, 2003, Vol.145 (4), p.614-621
15.
Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: is it safe?
by Joseph, Bellal, M.D
The American journal of surgery, 2015, Vol.209 (1), p.194-198
16.
Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism
by van Bellen, Bonno
Current medical research and opinion, 2014, Vol.30 (5), p.829-837
17.
Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits
by Dudley, Roy R
Journal of neurotrauma, 2010, Vol.27 (12), p.2165-2172
18.
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomi...
by Sherman, David G, Prof
The Lancet (British edition), 2007, Vol.369 (9570), p.1347-1355
19.
The effect anticoagulation status on geriatric fall trauma patients
by Coleman, Julia, MD MPH
The American journal of surgery, 2016, Vol.212 (6), p.1237-1242
20.
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies
by Kohn, Christine G.
Current medical research and opinion, 2017, Vol.33 (9), p.1697-1703
